CAR T-cell immunotherapy: The path from the by-road to the freeway?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T-cell immunotherapy: The path from the by-road to the freeway?

Published:2015-10-23 Issue:10 Volume:9 Page:1994-2018
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Whilding Lynsey M.,Maher John

Funder

Breast Cancer Now

Worldwide Cancer Research

Wellcome Trust

Cancer Research UK

Bayer Healthcare

Leukemia and Lymphoma Research

June Hancock Mesothelioma Research Fund

The Jon Moulton Charitable Foundation

Medical Research Council

Experimental Cancer Medicine Centre

National Institute for Health Research

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference234 articles.

1. Achkova , D. Spicer , J. Maher , J. 2015 Development of immunotherapy for anaplastic large cell lymphoma (ALCL) using CSF1R retargeted human T lymphocytes

2. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity;Adusumilli;Sci. Transl. Med,2014

3. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960;Ahmad;Br. J. Cancer,2015

4. Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma;Ahmed;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol,2015

5. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors;Ahmed;Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome;Pharmaceutical Research;2024-08-26

2. Car T Cells in Solid Tumors: Overcoming Obstacles;International Journal of Molecular Sciences;2024-04-10

3. CAR-T cell therapy for hematological malignancies: History, status and promise;Heliyon;2023-11

4. Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery;Pharmaceutics;2023-10-13

5. Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances;Frontiers in Immunology;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3